“ Why should Switzerland import a system that has patently been shown to be wrong-headed elsewhere and that will trigger drug shortages? ”
In Conversation
Katharina Gasser – Managing Director, Biogen Switzerland & Chair of the Executive Committee, Interpharma (October 2020)
“ We are happy and proud to be pioneers in neuroscience, but our pioneering work also requires us to keep pace with an increasingly ambiguous and changing… ”
Peter L. Saltonstall – President & CEO, National Organization for Rare Disorders (NORD), USA (October 2020)
“ With rare disease patients and families deeply affected by COVID-19, important policy issues at a critical point and scientific innovation advancing more rapidly than at any… ”
“ It will take some time but if the industry is able to continue to produce talent, new technology and solutions, diagnostic tools, and treatments, gradually the… ”
“ PPPs are not for everyone nor for everything – but for certain topics, they are the only way to make progress and tackle some huge challenges ”
“ Across research, development, and commercialization, our team is focused on advancing innovations that can address unmet needs, and we expect to see huge growth despite the… ”
“ Switzerland is very open to innovative products, and for a company like Janssen, which is focused on innovative, high-value products, we see good and strong uptake… ”
“ Through diligent and long-term thinking, and building bridges and trust with stakeholders, we have established a close partnership with patient organisations and several new modes of… ”
“ Through the acquisition and integration of Algeta, Bayer’s Norwegian operations have become one of the company’s global R&D and innovation hubs for radiopharmaceuticals. Radiopharmaceuticals in Norway,… ”
“ What our members want is a good and stable relationship with their most important trading partners, top among which is the EU ”
“ Culture eats strategy for breakfast – you can have the best strategy but if you do not work with the right culture or adjust to the… ”
“ Driving forward digital transformation is one of Bayer’s strategic priorities as we believe digitalization in healthcare has the potential to achieve game-changing efficiencies and drive a… ”